These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


659 related items for PubMed ID: 8097813

  • 1. Efficacy of hepatitis B vaccine in the Gambian expanded programme on immunisation.
    Fortuin M, Chotard J, Jack AD, Maine NP, Mendy M, Hall AJ, Inskip HM, George MO, Whittle HC.
    Lancet; 1993 May 01; 341(8853):1129-31. PubMed ID: 8097813
    [Abstract] [Full Text] [Related]

  • 2. Long-term efficacy of continuing hepatitis B vaccination in infancy in two Gambian villages.
    Whittle HC, Maine N, Pilkington J, Mendy M, Fortuin M, Bunn J, Allison L, Howard C, Hall A.
    Lancet; 1995 Apr 29; 345(8957):1089-92. PubMed ID: 7715343
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Hepatitis B vaccine in the Gambian Expanded Programme on Immunization: factors influencing antibody response.
    Inskip HM, Hall AJ, Chotard J, Loik F, Whittle H.
    Int J Epidemiol; 1991 Sep 29; 20(3):764-9. PubMed ID: 1835452
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. An efficacy trial of a mammalian cell-derived recombinant DNA hepatitis B vaccine in infants born to mothers positive for HBsAg, in Shanghai, China.
    Halliday ML, Kang LY, Rankin JG, Coates RA, Corey PN, Hu ZH, Zhou TK, Yuan GJ, Yao FL.
    Int J Epidemiol; 1992 Jun 29; 21(3):564-73. PubMed ID: 1386063
    [Abstract] [Full Text] [Related]

  • 10. Hepatitis B vaccine in the expanded programme of immunisation: The Gambian experience. The Gambia Hepatitis Study Group.
    Lancet; 1989 May 13; 1(8646):1057-9. PubMed ID: 2566008
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Significance and anamnestic response in isolated hepatitis B core antibody-positive individuals 18 years after neonatal hepatitis B virus vaccination in Taiwan.
    Su FH, Bai CH, Chu FY, Lin YS, Su CT, Yeh CC.
    Vaccine; 2012 Jun 08; 30(27):4034-9. PubMed ID: 22531558
    [Abstract] [Full Text] [Related]

  • 15. Hepatitis B vaccination in children: the Taiwan experience.
    Ni YH, Chen DS.
    Pathol Biol (Paris); 2010 Aug 08; 58(4):296-300. PubMed ID: 20116181
    [Abstract] [Full Text] [Related]

  • 16. Effectiveness of hepatitis-B vaccination in Ivory Coast: the case of the Grand Bassam health district.
    Magoni M, Ekra KD, Aka LN, Sita KS, Kanga K.
    Ann Trop Med Parasitol; 2009 Sep 08; 103(6):519-27. PubMed ID: 19695157
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Continuing risk for hepatitis B virus transmission among Southeast Asian infants in Louisiana.
    Mahoney FJ, Lawrence M, Scott C, Le Q, Lambert S, Farley TA.
    Pediatrics; 1995 Dec 08; 96(6):1113-6. PubMed ID: 7491231
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 33.